• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices

Initial Public Offering (IPO)

Fractyl Health goes the IPO route

February 2, 2024 By Chris Newmarker

Fractyl Health — developer of medtech and gene therapies to reverse diabetes and obesity — began trading on the Nasdaq today under the symbol GUTS. Lexington, Massachusetts–based Fractyl Health priced its 7,333,333 shares of common stock at $15 per share, enabling it to bring in about $110 million from the IPO. The company expected the […]

Filed Under: Business/Financial News, Diabetes, Featured, Funding Roundup, Initial Public Offering (IPO), Wall Street Beat, Weight loss Tagged With: Fractyl Health

Johnson & Johnson finalizes Kenvue spilt-off

August 23, 2023 By Sean Whooley

Johnson & Johnson announced today that it completed the separation of its Kenvue consumer health business. Kenvue completed its IPO in May 2023. Johnson & Johnson last month announced its intention to split off at least 80.1% of the shares of Kenvue. The separation enables the company to sharpen its focus on its MedTech and […]

Filed Under: Business/Financial News, Initial Public Offering (IPO), Mergers & Acquisitions, News Well, Wall Street Beat Tagged With: Johnson & Johnson, Johnson & Johnson MedTech

Bausch Health takes step toward separating Bausch+Lomb

August 22, 2022 By Sean Whooley

Bausch Health (NYSE:BHC) announced today that it transferred shares of its Bausch + Lomb to an existing subsidiary. The Laval, Quebec–based company transferred common shares in an amount equal to approximately 38.6% of the issued and outstanding shares of Bausch + Lomb to an existing, wholly-owned, unrestricted subsidiary of the company. According to a news […]

Filed Under: Business/Financial News, Funding Roundup, Initial Public Offering (IPO), Optical/Ophthalmic, Wall Street Beat Tagged With: Bausch + Lomb, bauschhealth

Bausch + Lomb CEO to step down

July 20, 2022 By Sean Whooley

Bausch + Lomb (NYSE:BLCO) announced today that Joseph C. Papa will step down as the company’s board chair and CEO. The optical and ophthalmic device maker has appointed Thomas W. Ross, Sr., to serve as its chair and has begun the search for a new CEO. Papa will remain as CEO and a member of […]

Filed Under: Business/Financial News, Funding Roundup, Initial Public Offering (IPO), Optical/Ophthalmic Tagged With: Bausch + Lomb, Personnel Moves

This CEO is swallowing his own devices to fund his swimming PillBot

March 14, 2022 By Jim Hammerand

As he prepared to swallow his robot for the first time, Torrey Smith’s doctors warned that the battery was his greatest threat. If the capsule came apart and the battery burned the tissue lining his stomach, it would only be the beginning of a very bad experience. “I was just hoping that we would get […]

Filed Under: 510(k), Blog, Business/Financial News, Catheters, Diagnostics, Endoscopic, Featured, Food & Drug Administration (FDA), Imaging, Initial Public Offering (IPO), News Well, Oncology, Optical/Ophthalmic, Regulatory/Compliance, Research & Development, Surgical Robotics Tagged With: Endiatx, Google, Mayo Clinic, Medtronic, Rani Therapeutics

BD board approves Embecta diabetes business spinoff

February 1, 2022 By Sean Whooley

BD (NYSE:BDX) announced today that its board of directors approved the planned spinoff of its diabetes care business, Embecta. Franklin Lakes, N.J.-based BD confirmed in May 2021 that it planned to spin off its diabetes care business as an independent, publicly-traded company during the first half of 2022, and in December 2021, it confirmed the […]

Filed Under: Business/Financial News, Diabetes, Drug Pumps, Drug-Device Combinations, Featured, Initial Public Offering (IPO), Wall Street Beat Tagged With: BD, embecta

Pear Therapeutics closes SPAC merger, lists on Nasdaq

December 6, 2021 By Sean Whooley

Pear Therapeutics today began trading on the Nasdaq market following the completion of a previously announced merger at the end of last week. Boston-based Pear confirmed in June that it would go public by merging Thimble Point Acquisition Corp., a special purpose acquisition company (SPAC). Following approval from Thimble Point’s stockholders at the end of […]

Filed Under: Business/Financial News, Digital Health, Featured, Funding Roundup, Health Technology, Initial Public Offering (IPO), MassDevice Earnings Roundup, Software / IT, Wall Street Beat Tagged With: Pear Therapeutics

Pear Therapeutics picks up another $50M ahead of going public through SPAC merger

November 15, 2021 By Sean Whooley

Pear Therapeutics and Thimble Point Acquisition Corp. announced today that they received additional funding worth $50 million ahead of a merger. Boston-based Pear Therapeutics confirmed in June that it will go public by merging Thimble Point Acquisition Corp., a special purpose acquisition company (SPAC). A special meeting will be held for Thimble Point stockholders to […]

Filed Under: Business/Financial News, Digital Health, Featured, Funding Roundup, Health Technology, Initial Public Offering (IPO), Mergers & Acquisitions, Neurological, Patient Monitoring, Software / IT, Wall Street Beat Tagged With: Pear Therapeutics, Thimble Point Acquisition Corp.

LumiraDx goes public as SPAC deal closes

September 29, 2021 By Chris Newmarker

LumiraDx shares are trading at more than $8 apiece on the Nasdaq today under the symbol LMDX after the company completed its merger with a SPAC called CA Healthcare Acquisition Corp. The point of care diagnostic testing company has a pipeline of more than 30 assays across common health conditions, including infectious diseases, cardiovascular diseases, […]

Filed Under: Business/Financial News, Diagnostics, Digital Health, Featured, Funding Roundup, Initial Public Offering (IPO), Wall Street Beat Tagged With: LumiraDX, SPAC, SPACs

Pavmed subsidiary Lucid Diagnostics files registration statement for IPO

September 23, 2021 By Sean Whooley

Pavmed (NSDQ:PAVM) subsidiary Lucid Diagnostics announced that Lucid publicly filed a registration statement related to a proposed initial public offering (IPO). The number of shares of common stock and the price range for the offering have not yet been determined, according to a news release. Lucid Diagnostics intends to list its common stock on the Nasdaq market […]

Filed Under: Business/Financial News, Diagnostics, Endoscopic, Featured, Funding Roundup, Initial Public Offering (IPO), Otolaryngology/Ear, Nose & Throat (ENT), Wall Street Beat Tagged With: Lucid Diagnostics, Pavmed

Vicarious Surgical stock continues to rise

September 21, 2021 By Chris Newmarker

It’s so far, so good for Vicarious Surgical (NYSE:RBOT) during its first week of trading as a public company. The robotic surgery company’s shares were up more than 19% to $15.05 by midday today. During the company’s first day of trading yesterday, shares rose 2% to $12.60 apiece, even as the Dow Jones Industrial Average […]

Filed Under: Business/Financial News, Featured, Funding Roundup, Initial Public Offering (IPO), Surgical, Surgical Robotics, Wall Street Beat Tagged With: SPACs, Vicarious Surgical

  • « Go to Previous Page
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Interim pages omitted …
  • Page 39
  • Go to Next Page »

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy